TheraSolve wins Biomedica 2015 Award for best Medtech Innovation
TheraSolve NV presented its MemoPatch® reminder technology at the European Life Sciences Summit Biomedica 2015 and has been elected by the members of the Biomedica Foundation Board as winner in the category Medtech.
Wim De Geest, CEO and co-founder of TheraSolve: “We are proud to win this international Biomedica award. TheraSolve is positioning itself as a genuine medication adherence innovator and could play a key role in major therapeutic areas like oncology, CNS, infectious diseases and many others. We are very honoured about the excellent feedback that we received from world class pharmaceutical companies and we look forward to bringing innovative applications of the MemoPatch® to patients around the globe.”
Only few patients accurately adhere to their medication prescriptions. Therapy non-adherence affects all players in the healthcare sector, most importantly the patient, since it results in an impaired therapy outcome. Several factors can contribute to a lack of therapy adherence, but most often, despite the many reminder systems currently available, patients simply forget to take their medication. These problems have encouraged the company to develop a very special skin patch which reminds patients to take their medication on time: MemoPatch®.
Other news from the department business & finance
